2 days agoAzithromycin protects against SO2 induced lung injuryWe are pleased to share some of our important finding at ERS (European Respiratory Society) International Congress this year. #EpiEndo #C...
Jan 16EpiEndo attends the 6th Annual LSX World Congress 2020The price of US oil has turned negative for the first time in history.
Dec 18, 2019EpiEndo Set to Receive a Grant From the European Innovation CouncilEpiEndo is very proud to be among 75 promising start-ups and SMEs to be selected by the European Innovation Council (EIC) to receive a grant
Sep 11, 2019EpiEndo attends RESI Boston 2019EpiEndo’s Founder, Fridrik Runar Gardarsson and Finnur Fridrik Einarsson (COO) will represent EpiEndo at the RESI conference in Boston on...
Sep 10, 2019EpiEndo Raises Eur 2 Million in EquityEpiEndo successfully closed our 4th seed round of 2 million Euros.
Sep 5, 2019Nordic Life Science Days 2019EpiEndo’s CEO, Fredrik Lehmann will represent EpiEndo at Nordic Life Science Days in Malmö on the 10th to 12th of September. He will also...
Sep 3, 2019Jennifer Kricker Joins EpiEndoEpiEndo welcomes Jennifer Kricker, PhD to the team. Jennifer will take the role of Project Director. Jennifer has been involved with EpiE...
Sep 1, 2019EpiEndo nominated for the Nordic Life Science Awards 2019EpiEndo has been nominated for the Nordic Life Science Business Class and Deligates choice Awards EpiEndo is among 9 BioTechs that are no...
Apr 4, 2019Professors Peter Barnes, Dave Singh and Carl Persson join EpiEndo's Scientific Advisory BoardEpiEndo is proud to introduce new external advisers to our Scientific Advisory Board (SAB) and welcome Professors Peter Barnes, Dave Sing...
Jan 17, 2019EpiEndo Pharmaceuticals Raises €800,000 to Advance Breakthrough Treatments for Respiratory DiseasesEpiEndo is pleased to announce that we have successfully closed a financing round of ISK 110 million (800.000 EUR). The financing was led...
Sep 1, 2018Fredrik Lehmann appointed CEO of EpiEndoEpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo. Fredrik has a PhD in Medicinal Chemistry from the Un...
Jun 29, 2018Grant from the Icelandic Technology Development FundEpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo. EpiEndo Pharmaceuticals has signed a grant agreement...
Mar 18, 2017New board members join EpiEndo PharmaceuticalsThe following were appointed to the board of EpiEndo Pharmaceuticals at the Annual General Meeting on 17 March 2017. Professor Clive Page...
Jan 31, 2017EpiEndo Pharmaceuticals is granted EU Horizon 2020 awardEpiEndo Pharmaceuticals are proud to announce that we have been granted a Horizon 2020 grant from the European Union (EU) for the feasibi...
May 25, 2016EpiEndo Pharmaceuticals receives RANNIS Technology Development Fund awardEpiEndo Pharmaceuticals is proud to announce that we have received a 3 year grant from the Technology Development Fund, which is managed ...
Oct 11, 2014EpiEndo Pharmaceuticals announces new partnership with RecipharmEpiEndo Pharmaceuticals are proud to announce our new partnership with Recipharm, a Swedish Contract Development and Manufacturing Organi...
Jun 2, 2014EpiEndo Pharmaceuticals awarded RANNIS Innovator GrantEpiEndo Pharmaceuticals has been granted a 2 year grant by RANNÍS - The Icelandic Centre for Research - for compound research and patent ...
